LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged mootness · clear

PTAB

MOMENTA PHARMACEUTICALS, INC. v. BRISTOL-MYERS SQUIBB COMPANY

Federal Circuit Summary Before Newman , Dyk, and Chen. Appeal from the Patent Trial and Appeal Board. Summary : An injury-in-fact is required to establish Article III standing for judicial review of agency action, even if a statute permits such review.…

February 7, 2019·PTAB·1 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.